Cytokine level in patients with mood disorder, alcohol use disorder and their comorbidity

References

• Adams C, Conigrave JH, Lewohl J, Haber P, Morley KC. 2020. Alcohol use disorder and circulating cytokines: a systematic review and meta-analysis. Brain Behav Immun. 89:501–512. 10.1016/j.bbi.2020.08.002.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association 1994. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington (DC): American Psychiatric Association.
   Google Scholar
• Antolin-Fontes B, Ables JL, Görlich A, Ibañez-Tallon I. 2015. The habenulo-interpeduncular pathway in nicotine aversion and withdrawal. Neuropharmacology. 96(Pt B):213–222.
   PubMedGoogle Scholar
• Archer M, Niemelä O, Luoto K, Kultti J, Hämäläinen M, Moilanen E, Koivukangas A, Leinonen E, Kampman O. 2019. Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorder. Alcohol. 81:21–26.
   PubMedGoogle Scholar
• Audet MC, McQuaid RJ, Merali Z, Anisman H. 2014. Cytokine variations and mood disorders: influence of social stressors and social support. Front Neurosci. 8:416.
   PubMedGoogle Scholar
• Baraldi S, Hepgul N, Mondelli V, Pariante CM. 2012. Symptomatic treatment of interferon-α-induced depression in hepatitis C: a systematic review. J Clin Psychopharmacol. 32(4):531–543.
   PubMedGoogle Scholar
• Batalla A, Homberg JR, Lipina TV, Sescousse G, Luijten M, Ivanova SA, Schellekens AFA, Loonen AJM. 2017. The role of the habenula in the transition from reward to misery in substance use and mood disorders. Neurosci Biobehav Rev. 80:276–285.
   PubMed Web of Science ®Google Scholar
• Boden JM, Fergusson DM. 2011. Alcohol and depression. Addiction. 106(5):906–914.
   PubMed Web of Science ®Google Scholar
• Cassidy EM, Manning D, Byrne S, Bolger E, Murray F, Sharifi N, Wallace E, Keogan M, O'Keane V. 2002. Acute effects of low-dose interferon-alpha on serum cortisol and plasma interleukin-6. J Psychopharmacol. 16(3):230–234.
   PubMedGoogle Scholar
• Cavanagh A, Wilson CJ, Kavanagh DJ, Caputi P. 2017. Differences in the expression of symptoms in men versus women with depression: a systematic review and meta-analysis. Harv Rev Psychiatry. 25(1):29–38.
   PubMed Web of Science ®Google Scholar
• Chen Y, Dai J, Liang Q, Tang L, Mikhailova T, Li M, Liu C. 2022. The neuroimmune changes captured by transcriptome in brains of psychiatric and neurological disorders. medRxiv. 2022.02.14.22269692.
   Google Scholar
• Clerici M, Arosio B, Mundo E, Cattaneo E, Pozzoli S, Dell'Osso B, Vergani C, Trabattoni D, Altamura AC. 2009. Cytokine polymorphisms in the pathophysiology of mood disorders. CNS Spectr. 14(8):419–425.
   PubMedGoogle Scholar
• Costello EJ, Copeland WE, Shanahan L, Worthman CM, Angold A. 2013. C-reactive protein and substance use disorders in adolescence and early adulthood: a prospective analysis. Drug Alcohol Depend. 133(2):712–717.
   PubMed Web of Science ®Google Scholar
• Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J. 2006. Cytokines and alcohol. Alcohol Clin Exp Res. 30(4):720–730.
   PubMed Web of Science ®Google Scholar
• Crews FT. 2012. Immune function genes, genetics, and the neurobiology of addiction. Alcohol Res: Curr Rev. 34(3):355.
   Google Scholar
• Debnath M, Berk M, Maes M. 2021. Translational evidence for the inflammatory response system (IRS)/compensatory immune response system (CIRS) and neuroprogression theory of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 111:110343.
   PubMedGoogle Scholar
• Dossi E, Vasile F, Rouach N. 2018. Human astrocytes in the diseased brain. Brain Res Bull. 136:139–156.
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL. 2010. A meta-analysis of cytokines in major depression. Biol Psychiatry. 67(5):446–457.
   PubMed Web of Science ®Google Scholar
• Durstewitz D, Koppe G, Meyer-Lindenberg A. 2019. Deep neural networks in psychiatry. Mol Psychiatry. 24(11):1583–1598.
   PubMed Web of Science ®Google Scholar
• Ehret M, Sobieraj DM. 2014. Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis. Int J Clin Pract. 68(2):255–261.
   PubMedGoogle Scholar
• Fujimoto M, Uemura M, Nakatani Y, Tsujita S, Hoppo K, Tamagawa T, Kitano H, Kikukawa M, Ann T, Ishii Y, et al. 2000. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res. 24(4 Suppl):48S–54S.
   PubMed Web of Science ®Google Scholar
• Girgus JS, Yang K, Ferri CV. 2017. The gender difference in depression: are elderly women at greater risk for depression than elderly men? Geriatrics (Basel). 2(4):35.
   PubMedGoogle Scholar
• Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K. 2004. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 61(8):807–816.
   PubMed Web of Science ®Google Scholar
• Guan YF, Huang GB, Xu MD, Gao F, Lin S, Huang J, Wang J, Li YQ, Wu CH, Yao S, et al. 2020. Anti-depression effects of ketogenic diet are mediated via the restoration of microglial activation and neuronal excitability in the lateral habenula. Brain Behav Immun. 88:748–762.
   PubMed Web of Science ®Google Scholar
• Hillmer AT, Nadim H, Devine L, Jatlow P, O'Malley SS. 2020. Acute alcohol consumption alters the peripheral cytokines IL-8 and TNF-α. Alcohol. 85:95–99.
   PubMedGoogle Scholar
• Hoyo-Becerra C, Schlaak JF, Hermann DM. 2014. Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation. Brain Behav Immun. 42:222–231.
   PubMed Web of Science ®Google Scholar
• Hunt GE, Malhi GS, Lai HMX, Cleary M. 2020. Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990–2019: systematic review and meta-analysis. J Affect Disord. 266:288–304.
   PubMed Web of Science ®Google Scholar
• Ito H, Nozaki K, Sakimura K, Abe M, Yamawaki S, Aizawa H. 2021. Activation of proprotein convertase in the mouse habenula causes depressive-like behaviors through remodeling of extracellular matrix. Neuropsychopharmacology. 46(2):442–454.
   PubMedGoogle Scholar
• Jia X, Gao Z, Hu H. 2021. Microglia in depression: current perspectives. Sci China Life Sci. 64(6):911–925.
   PubMedGoogle Scholar
• Jiang HY, Deng M, Zhang YH, Chen HZ, Chen Q, Ruan B. 2014. Specific serotonin reuptake inhibitors prevent interferon-α-induced depression in patients with hepatitis C: a meta-analysis. Clin Gastroenterol Hepatol. 12(9):1452–1460.e3.
   PubMedGoogle Scholar
• Kessler RC. 2003. Epidemiology of women and depression. J Affect Disord. 74(1):5–13.
   PubMed Web of Science ®Google Scholar
• Köhler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann N, et al. 2017. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 135(5):373–387.
   PubMed Web of Science ®Google Scholar
• Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. 2000. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 22(4):370–379. 10.1016/S0893-133X(99)00134-7.
   PubMed Web of Science ®Google Scholar
• Leclercq S, Cani PD, Neyrinck AM, Stärkel P, Jamar F, Mikolajczak M, Delzenne NM, de Timary P. 2012. Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects. Brain Behav Immun. 26(6):911–918.
   PubMed Web of Science ®Google Scholar
• Leclercq S, De Saeger C, Delzenne N, de Timary P, Stärkel P. 2014. Role of inflammatory pathways, blood mononuclear cells, and gut-derived bacterial products in alcohol dependence. Biol Psychiatry. 76(9):725–733.
   PubMed Web of Science ®Google Scholar
• Levchuk LA, Meeder EMG, Roschina OV, Loonen AJM, Boiko AS, Michalitskaya EV, Epimakhova EV, Losenkov IS, Simutkin GG, Bokhan NA, et al. 2020. Exploring brain derived neurotrophic factor and cell adhesion molecules as biomarkers for the transdiagnostic symptom anhedonia in alcohol use disorder and comorbid depression. Front Psychiatry. 11:296.
   PubMedGoogle Scholar
• Liu JJ, Wei YB, Strawbridge R, Bao Y, Chang S, Shi L, Que J, Gadad BS, Trivedi MH, Kelsoe JR, et al. 2020. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis. Mol Psychiatry. 25(2):339–350.
   PubMed Web of Science ®Google Scholar
• Loonen AJM, Ivanova SA. 2016a. Circuits regulating pleasure and happiness-mechanisms of depression. Front Hum Neurosci. 10:571.
   PubMedGoogle Scholar
• Loonen AJM, Ivanova SA. 2016b. Circuits regulating pleasure and happiness in major depression. Med Hypotheses. 87:14–21.
   PubMed Web of Science ®Google Scholar
• Loonen AJM, Ivanova SA. 2018. Circuits regulating pleasure and happiness: evolution and role in mental disorders. Acta Neuropsychiatr. 30(1):29–42.
   PubMed Web of Science ®Google Scholar
• Machado MO, Oriolo G, Bortolato B, Köhler CA, Maes M, Solmi M, Grande I, Martín-Santos R, Vieta E, Carvalho AF. 2017. Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: a critical systematic review. J Affect Disord. 209:235–245.
   PubMed Web of Science ®Google Scholar
• Małyszczak K, Inglot M, Frydecka D, Hadryś T, Pawłowski T. 2019. Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C. Adv Clin Exp Med. 28(9):1217–1222.
   PubMedGoogle Scholar
• Marmorstein NR. 2009. Longitudinal associations between alcohol problems and depressive symptoms: early adolescence through early adulthood. Alcohol Clin Exp Res. 33(1):49–59.
   PubMed Web of Science ®Google Scholar
• Martinez P, Lien L, Zemore S, Bramness JG, Neupane SP. 2018. Circulating cytokine levels are associated with symptoms of depression and anxiety among people with alcohol and drug use disorders. J Neuroimmunol. 318:80–86.
   PubMedGoogle Scholar
• McHugh RK, Weiss RD. 2019. Alcohol use disorder and depressive disorders. ARCR. 40(1):arcr.v40.1.01.
   Google Scholar
• Miller AH, Maletic V, Raison CL. 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 65(9):732–741.
   PubMed Web of Science ®Google Scholar
• Neupane SP, Lien L, Martinez P, Aukrust P, Ueland T, Mollnes TE, Hestad K, Bramness JG. 2014. High frequency and intensity of drinking may attenuate increased inflammatory cytokine levels of major depression in alcohol-use disorders. CNS Neurosci Ther. 20(10):898–904.
   PubMedGoogle Scholar
• Neupane SP. 2016. Neuroimmune interface in the comorbidity between alcohol use disorder and major depression. Front Immunol. 7:655.
   PubMed Web of Science ®Google Scholar
• Pandey GN, Rizavi HS, Zhang H, Bhaumik R, Ren X. 2018. Abnormal protein and mRNA expression of inflammatory cytokines in the prefrontal cortex of depressed individuals who died by suicide. J Psychiatry Neurosci. 43(6):376–385.
   PubMedGoogle Scholar
• Petralia MC, Mazzon E, Fagone P, Basile MS, Lenzo V, Quattropani MC, Di Nuovo S, Bendtzen K, Nicoletti F. 2020. The cytokine network in the pathogenesis of major depressive disorder. Close to translation? Autoimmun Rev. 19(5):102504.
   PubMed Web of Science ®Google Scholar
• Prather AA, Rabinovitz M, Pollock BG, Lotrich FE. 2009. Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality. Brain Behav Immun. 23(8):1109–1116.
   PubMed Web of Science ®Google Scholar
• Rehm J, Shield KD. 2019. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 21(2):10.
   PubMed Web of Science ®Google Scholar
• Saha S, Lim CC, Degenhardt L, Cannon DL, Bremner M, Prentis F, Lawrence Z, Heffernan E, Meurk C, Reilly J, et al. 2022. Comorbidity between mood and substance-related disorders: a systematic review and meta-analysis. Aust N Z J Psychiatry. 5648674211054740. (7):757–770.
   PubMedGoogle Scholar
• Sarkar S, Schaefer M. 2014. Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis. Psychosomatics. 55(3):221–234.
   PubMedGoogle Scholar
• Schaefer M, Schwaiger M, Pich M, Lieb K, Heinz A. 2003. Neurotransmitter changes by interferon-alpha and therapeutic implications. Pharmacopsychiatry. 36(Suppl 3):S203–S206.
   PubMedGoogle Scholar
• Song C, Halbreich U, Han C, Leonard BE, Luo H. 2009. Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry. 42(5):182–188.
   PubMed Web of Science ®Google Scholar
• Starkenburg S, Munroe ME, Waltenbaugh C. 2001. Early alteration in leukocyte populations and Th1/Th2 function in ethanol-consuming mice. Alcohol Clin Exp Res. 25(8):1221–1230.
   PubMed Web of Science ®Google Scholar
• Stoyanov D, Maes MH. 2021. How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychiatry. World J Psychiatry. 11(1):1–12.
   PubMed Web of Science ®Google Scholar
• Sullivan LE, Fiellin DA, O'Connor PG. 2005. The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med. 118(4):330–341.
   PubMed Web of Science ®Google Scholar
• Szabo G, Mandrekar P. 2009. A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res. 33(2):220–232.
   PubMed Web of Science ®Google Scholar
• Udina M, Castellví P, Moreno-España J, Navinés R, Valdés M, Forns X, Langohr K, Solà R, Vieta E, Martín-Santos R. 2012. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry. 73(8):1128–1138.
   PubMed Web of Science ®Google Scholar
• Uint L, Bastos GM, Thurow HS, Borges JB, Hirata TDC, França JID, Hirata MH, Sousa AGMR. 2019. Increased levels of plasma IL-1b and BDNF can predict resistant depression patients. Rev Assoc Med Bras. (1992). 65(3):361–369.
   PubMedGoogle Scholar
• Underwood MD, Kassir SA, Bakalian MJ, Galfalvy H, Dwork AJ, Mann JJ, Arango V. 2018. Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity. Transl Psychiatry. 8(1):279.
   PubMedGoogle Scholar
• Vasilieva SN, Simutkin GG, Schastnyy ED, Bokhan NA. 2021. Clinical-dynamic features of affective disorders comorbid with alcohol dependence. Int J Ment Health Addiction. 19(5):1443–1451.
   Google Scholar
• Walther A, Rice T, Kufert Y, Ehlert U. 2016. Neuroendocrinology of a male-specific pattern for depression linked to alcohol use disorder and suicidal behavior. Front Psychiatry. 7:206. 2017
   PubMedGoogle Scholar
• Warden A, Erickson E, Robinson G, Harris RA, Mayfield RD. 2016. The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies. Pharmacogenomics. 17(18):2081–2096.
   PubMed Web of Science ®Google Scholar
• World Health Organization 2004. International statistical classification of diseases and health related problems ICD-10. World Health Organization: Geneva (CH).
   Google Scholar
• Zhao YW, Pan YQ, Tang MM, Lin WJ. 2018. Blocking p38 signaling reduces the activation of pro-inflammatory cytokines and the phosphorylation of p38 in the habenula and reverses depressive-like behaviors induced by neuroinflammation. Front Pharmacol. 9:511.
   PubMedGoogle Scholar